nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Vemurafenib—skin cancer	0.3	0.498	CbGbCtD
Zoledronate—ABCC1—Dactinomycin—skin cancer	0.199	0.331	CbGbCtD
Zoledronate—ABCC1—Docetaxel—skin cancer	0.103	0.171	CbGbCtD
Zoledronate—GGPS1—hair follicle—skin cancer	0.0111	0.124	CbGeAlD
Zoledronate—GGPS1—nipple—skin cancer	0.00753	0.0844	CbGeAlD
Zoledronate—FDPS—Sorafenib—Vismodegib—skin cancer	0.00753	1	CbGdCrCtD
Zoledronate—GGPS1—connective tissue—skin cancer	0.00534	0.0598	CbGeAlD
Zoledronate—FDPS—hair follicle—skin cancer	0.00512	0.0574	CbGeAlD
Zoledronate—GGPS1—mammalian vulva—skin cancer	0.0044	0.0493	CbGeAlD
Zoledronate—GGPS1—lymphoid tissue—skin cancer	0.00391	0.0438	CbGeAlD
Zoledronate—GGPS1—female reproductive system—skin cancer	0.00377	0.0422	CbGeAlD
Zoledronate—FDPS—nipple—skin cancer	0.00347	0.0389	CbGeAlD
Zoledronate—GGPS1—head—skin cancer	0.00315	0.0353	CbGeAlD
Zoledronate—ABCC1—hair follicle—skin cancer	0.00297	0.0333	CbGeAlD
Zoledronate—CA2—hair follicle—skin cancer	0.00266	0.0298	CbGeAlD
Zoledronate—CA12—connective tissue—skin cancer	0.00249	0.0279	CbGeAlD
Zoledronate—FDPS—connective tissue—skin cancer	0.00246	0.0276	CbGeAlD
Zoledronate—FDPS—skin of body—skin cancer	0.00222	0.0249	CbGeAlD
Zoledronate—GGPS1—lymph node—skin cancer	0.0022	0.0247	CbGeAlD
Zoledronate—FDPS—mammalian vulva—skin cancer	0.00203	0.0227	CbGeAlD
Zoledronate—ABCC1—nipple—skin cancer	0.00202	0.0226	CbGeAlD
Zoledronate—Risedronate—PTGS2—skin cancer	0.00192	0.529	CrCbGaD
Zoledronate—CA2—nipple—skin cancer	0.0018	0.0202	CbGeAlD
Zoledronate—FDPS—lymphoid tissue—skin cancer	0.0018	0.0202	CbGeAlD
Zoledronate—CA2—neck—skin cancer	0.00178	0.02	CbGeAlD
Zoledronate—CA12—female reproductive system—skin cancer	0.00176	0.0197	CbGeAlD
Zoledronate—FDPS—female reproductive system—skin cancer	0.00174	0.0195	CbGeAlD
Zoledronate—Clodronate—PTGS2—skin cancer	0.00171	0.471	CrCbGaD
Zoledronate—CA12—head—skin cancer	0.00147	0.0164	CbGeAlD
Zoledronate—FDPS—head—skin cancer	0.00145	0.0163	CbGeAlD
Zoledronate—CA2—connective tissue—skin cancer	0.00128	0.0143	CbGeAlD
Zoledronate—CA2—epithelium—skin cancer	0.00121	0.0136	CbGeAlD
Zoledronate—ABCC1—mammalian vulva—skin cancer	0.00118	0.0132	CbGeAlD
Zoledronate—CA2—skin of body—skin cancer	0.00115	0.0129	CbGeAlD
Zoledronate—CA2—mammalian vulva—skin cancer	0.00105	0.0118	CbGeAlD
Zoledronate—FDPS—lymph node—skin cancer	0.00102	0.0114	CbGeAlD
Zoledronate—CA2—lymphoid tissue—skin cancer	0.000935	0.0105	CbGeAlD
Zoledronate—CA2—female reproductive system—skin cancer	0.000902	0.0101	CbGeAlD
Zoledronate—CA2—head—skin cancer	0.000753	0.00844	CbGeAlD
Zoledronate—ABCC1—lymph node—skin cancer	0.00059	0.00661	CbGeAlD
Zoledronate—CA2—lymph node—skin cancer	0.000528	0.00591	CbGeAlD
Zoledronate—Chills—Temozolomide—skin cancer	0.00033	0.00111	CcSEcCtD
Zoledronate—Dehydration—Docetaxel—skin cancer	0.000329	0.0011	CcSEcCtD
Zoledronate—Ill-defined disorder—Dactinomycin—skin cancer	0.000328	0.0011	CcSEcCtD
Zoledronate—Anaemia—Dactinomycin—skin cancer	0.000327	0.0011	CcSEcCtD
Zoledronate—Vomiting—Vemurafenib—skin cancer	0.000325	0.00109	CcSEcCtD
Zoledronate—Alopecia—Temozolomide—skin cancer	0.000325	0.00109	CcSEcCtD
Zoledronate—Chest pain—Bleomycin—skin cancer	0.000323	0.00108	CcSEcCtD
Zoledronate—Myalgia—Bleomycin—skin cancer	0.000323	0.00108	CcSEcCtD
Zoledronate—Abdominal pain upper—Docetaxel—skin cancer	0.000323	0.00108	CcSEcCtD
Zoledronate—Rash—Vemurafenib—skin cancer	0.000322	0.00108	CcSEcCtD
Zoledronate—Mental disorder—Temozolomide—skin cancer	0.000322	0.00108	CcSEcCtD
Zoledronate—Dermatitis—Vemurafenib—skin cancer	0.000322	0.00108	CcSEcCtD
Zoledronate—Hypersensitivity—Imiquimod—skin cancer	0.000321	0.00108	CcSEcCtD
Zoledronate—Headache—Vemurafenib—skin cancer	0.00032	0.00107	CcSEcCtD
Zoledronate—Malnutrition—Temozolomide—skin cancer	0.00032	0.00107	CcSEcCtD
Zoledronate—Erythema—Temozolomide—skin cancer	0.00032	0.00107	CcSEcCtD
Zoledronate—Discomfort—Bleomycin—skin cancer	0.000319	0.00107	CcSEcCtD
Zoledronate—Malaise—Dactinomycin—skin cancer	0.000319	0.00107	CcSEcCtD
Zoledronate—Cramp muscle—Docetaxel—skin cancer	0.000318	0.00107	CcSEcCtD
Zoledronate—Leukopenia—Dactinomycin—skin cancer	0.000317	0.00106	CcSEcCtD
Zoledronate—Nasopharyngitis—Docetaxel—skin cancer	0.000316	0.00106	CcSEcCtD
Zoledronate—Dysgeusia—Temozolomide—skin cancer	0.000314	0.00105	CcSEcCtD
Zoledronate—Asthenia—Imiquimod—skin cancer	0.000313	0.00105	CcSEcCtD
Zoledronate—Confusional state—Bleomycin—skin cancer	0.000312	0.00105	CcSEcCtD
Zoledronate—Anaphylactic shock—Bleomycin—skin cancer	0.00031	0.00104	CcSEcCtD
Zoledronate—Oedema—Bleomycin—skin cancer	0.00031	0.00104	CcSEcCtD
Zoledronate—Back pain—Temozolomide—skin cancer	0.00031	0.00104	CcSEcCtD
Zoledronate—Pruritus—Imiquimod—skin cancer	0.000308	0.00104	CcSEcCtD
Zoledronate—Infection—Bleomycin—skin cancer	0.000308	0.00103	CcSEcCtD
Zoledronate—Dysphagia—Docetaxel—skin cancer	0.000306	0.00103	CcSEcCtD
Zoledronate—Nausea—Vemurafenib—skin cancer	0.000304	0.00102	CcSEcCtD
Zoledronate—Thrombocytopenia—Bleomycin—skin cancer	0.000303	0.00102	CcSEcCtD
Zoledronate—Arrhythmia—Fluorouracil—skin cancer	0.000303	0.00102	CcSEcCtD
Zoledronate—Vision blurred—Temozolomide—skin cancer	0.000302	0.00101	CcSEcCtD
Zoledronate—Myalgia—Dactinomycin—skin cancer	0.000301	0.00101	CcSEcCtD
Zoledronate—Bronchospasm—Docetaxel—skin cancer	0.000301	0.00101	CcSEcCtD
Zoledronate—Tremor—Temozolomide—skin cancer	0.0003	0.00101	CcSEcCtD
Zoledronate—Alopecia—Fluorouracil—skin cancer	0.000299	0.001	CcSEcCtD
Zoledronate—Diarrhoea—Imiquimod—skin cancer	0.000298	0.001	CcSEcCtD
Zoledronate—Discomfort—Dactinomycin—skin cancer	0.000298	0.000999	CcSEcCtD
Zoledronate—Ill-defined disorder—Temozolomide—skin cancer	0.000297	0.000997	CcSEcCtD
Zoledronate—Anaemia—Temozolomide—skin cancer	0.000296	0.000993	CcSEcCtD
Zoledronate—Anorexia—Bleomycin—skin cancer	0.000295	0.000991	CcSEcCtD
Zoledronate—Erythema—Fluorouracil—skin cancer	0.000295	0.00099	CcSEcCtD
Zoledronate—Agitation—Temozolomide—skin cancer	0.000294	0.000987	CcSEcCtD
Zoledronate—Angioedema—Temozolomide—skin cancer	0.000293	0.000982	CcSEcCtD
Zoledronate—Pancytopenia—Docetaxel—skin cancer	0.00029	0.000974	CcSEcCtD
Zoledronate—Hypotension—Bleomycin—skin cancer	0.000289	0.000971	CcSEcCtD
Zoledronate—Oedema—Dactinomycin—skin cancer	0.000289	0.000969	CcSEcCtD
Zoledronate—Malaise—Temozolomide—skin cancer	0.000289	0.000969	CcSEcCtD
Zoledronate—Dizziness—Imiquimod—skin cancer	0.000288	0.000967	CcSEcCtD
Zoledronate—Vertigo—Temozolomide—skin cancer	0.000288	0.000965	CcSEcCtD
Zoledronate—Infection—Dactinomycin—skin cancer	0.000287	0.000963	CcSEcCtD
Zoledronate—Leukopenia—Temozolomide—skin cancer	0.000287	0.000962	CcSEcCtD
Zoledronate—Neutropenia—Docetaxel—skin cancer	0.000286	0.000959	CcSEcCtD
Zoledronate—Palpitations—Temozolomide—skin cancer	0.000283	0.000949	CcSEcCtD
Zoledronate—Thrombocytopenia—Dactinomycin—skin cancer	0.000283	0.000949	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000282	0.000947	CcSEcCtD
Zoledronate—Cough—Temozolomide—skin cancer	0.000279	0.000937	CcSEcCtD
Zoledronate—Paraesthesia—Bleomycin—skin cancer	0.000278	0.000933	CcSEcCtD
Zoledronate—Weight increased—Docetaxel—skin cancer	0.000278	0.000933	CcSEcCtD
Zoledronate—Vision blurred—Fluorouracil—skin cancer	0.000278	0.000933	CcSEcCtD
Zoledronate—Convulsion—Temozolomide—skin cancer	0.000277	0.000931	CcSEcCtD
Zoledronate—Vomiting—Imiquimod—skin cancer	0.000277	0.00093	CcSEcCtD
Zoledronate—Weight decreased—Docetaxel—skin cancer	0.000276	0.000928	CcSEcCtD
Zoledronate—Hypertension—Temozolomide—skin cancer	0.000276	0.000927	CcSEcCtD
Zoledronate—Dyspnoea—Bleomycin—skin cancer	0.000276	0.000927	CcSEcCtD
Zoledronate—Anorexia—Dactinomycin—skin cancer	0.000275	0.000924	CcSEcCtD
Zoledronate—Rash—Imiquimod—skin cancer	0.000275	0.000922	CcSEcCtD
Zoledronate—Dermatitis—Imiquimod—skin cancer	0.000275	0.000922	CcSEcCtD
Zoledronate—Headache—Imiquimod—skin cancer	0.000273	0.000916	CcSEcCtD
Zoledronate—Anaemia—Fluorouracil—skin cancer	0.000273	0.000915	CcSEcCtD
Zoledronate—Arthralgia—Temozolomide—skin cancer	0.000273	0.000915	CcSEcCtD
Zoledronate—Myalgia—Temozolomide—skin cancer	0.000273	0.000915	CcSEcCtD
Zoledronate—Infestation NOS—Docetaxel—skin cancer	0.000272	0.000914	CcSEcCtD
Zoledronate—Infestation—Docetaxel—skin cancer	0.000272	0.000914	CcSEcCtD
Zoledronate—Anxiety—Temozolomide—skin cancer	0.000272	0.000911	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000271	0.000908	CcSEcCtD
Zoledronate—Discomfort—Temozolomide—skin cancer	0.000269	0.000904	CcSEcCtD
Zoledronate—Decreased appetite—Bleomycin—skin cancer	0.000269	0.000903	CcSEcCtD
Zoledronate—Renal failure—Docetaxel—skin cancer	0.000268	0.000899	CcSEcCtD
Zoledronate—Dry mouth—Temozolomide—skin cancer	0.000267	0.000894	CcSEcCtD
Zoledronate—Stomatitis—Docetaxel—skin cancer	0.000266	0.000891	CcSEcCtD
Zoledronate—Pain—Bleomycin—skin cancer	0.000265	0.000889	CcSEcCtD
Zoledronate—Conjunctivitis—Docetaxel—skin cancer	0.000265	0.000889	CcSEcCtD
Zoledronate—Leukopenia—Fluorouracil—skin cancer	0.000264	0.000886	CcSEcCtD
Zoledronate—Confusional state—Temozolomide—skin cancer	0.000263	0.000884	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000263	0.000883	CcSEcCtD
Zoledronate—Anaphylactic shock—Temozolomide—skin cancer	0.000261	0.000877	CcSEcCtD
Zoledronate—Oedema—Temozolomide—skin cancer	0.000261	0.000877	CcSEcCtD
Zoledronate—Infection—Temozolomide—skin cancer	0.00026	0.000871	CcSEcCtD
Zoledronate—Nausea—Imiquimod—skin cancer	0.000259	0.000869	CcSEcCtD
Zoledronate—Nervous system disorder—Temozolomide—skin cancer	0.000256	0.00086	CcSEcCtD
Zoledronate—Thrombocytopenia—Temozolomide—skin cancer	0.000256	0.000858	CcSEcCtD
Zoledronate—Convulsion—Fluorouracil—skin cancer	0.000256	0.000858	CcSEcCtD
Zoledronate—Feeling abnormal—Bleomycin—skin cancer	0.000255	0.000856	CcSEcCtD
Zoledronate—Agranulocytosis—Docetaxel—skin cancer	0.000254	0.000853	CcSEcCtD
Zoledronate—Skin disorder—Temozolomide—skin cancer	0.000254	0.000852	CcSEcCtD
Zoledronate—Hyperhidrosis—Temozolomide—skin cancer	0.000253	0.000848	CcSEcCtD
Zoledronate—Chest pain—Fluorouracil—skin cancer	0.000251	0.000843	CcSEcCtD
Zoledronate—Myalgia—Fluorouracil—skin cancer	0.000251	0.000843	CcSEcCtD
Zoledronate—Decreased appetite—Dactinomycin—skin cancer	0.000251	0.000843	CcSEcCtD
Zoledronate—Fatigue—Dactinomycin—skin cancer	0.000249	0.000836	CcSEcCtD
Zoledronate—Anorexia—Temozolomide—skin cancer	0.000249	0.000836	CcSEcCtD
Zoledronate—Discomfort—Fluorouracil—skin cancer	0.000248	0.000833	CcSEcCtD
Zoledronate—Pain—Dactinomycin—skin cancer	0.000247	0.000829	CcSEcCtD
Zoledronate—Urticaria—Bleomycin—skin cancer	0.000246	0.000826	CcSEcCtD
Zoledronate—Body temperature increased—Bleomycin—skin cancer	0.000245	0.000822	CcSEcCtD
Zoledronate—Hypoaesthesia—Docetaxel—skin cancer	0.000243	0.000816	CcSEcCtD
Zoledronate—Confusional state—Fluorouracil—skin cancer	0.000243	0.000814	CcSEcCtD
Zoledronate—Urinary tract disorder—Docetaxel—skin cancer	0.000242	0.00081	CcSEcCtD
Zoledronate—Oedema peripheral—Docetaxel—skin cancer	0.000241	0.000808	CcSEcCtD
Zoledronate—Anaphylactic shock—Fluorouracil—skin cancer	0.000241	0.000808	CcSEcCtD
Zoledronate—Oedema—Fluorouracil—skin cancer	0.000241	0.000808	CcSEcCtD
Zoledronate—Connective tissue disorder—Docetaxel—skin cancer	0.00024	0.000806	CcSEcCtD
Zoledronate—Urethral disorder—Docetaxel—skin cancer	0.00024	0.000804	CcSEcCtD
Zoledronate—Infection—Fluorouracil—skin cancer	0.000239	0.000802	CcSEcCtD
Zoledronate—Feeling abnormal—Dactinomycin—skin cancer	0.000238	0.000799	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000238	0.000799	CcSEcCtD
Zoledronate—Insomnia—Temozolomide—skin cancer	0.000236	0.000793	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000236	0.000793	CcSEcCtD
Zoledronate—Nervous system disorder—Fluorouracil—skin cancer	0.000236	0.000792	CcSEcCtD
Zoledronate—Thrombocytopenia—Fluorouracil—skin cancer	0.000236	0.000791	CcSEcCtD
Zoledronate—Tachycardia—Fluorouracil—skin cancer	0.000235	0.000788	CcSEcCtD
Zoledronate—Paraesthesia—Temozolomide—skin cancer	0.000235	0.000787	CcSEcCtD
Zoledronate—Dyspnoea—Temozolomide—skin cancer	0.000233	0.000782	CcSEcCtD
Zoledronate—Somnolence—Temozolomide—skin cancer	0.000232	0.000779	CcSEcCtD
Zoledronate—Dyspepsia—Temozolomide—skin cancer	0.00023	0.000772	CcSEcCtD
Zoledronate—Anorexia—Fluorouracil—skin cancer	0.000229	0.00077	CcSEcCtD
Zoledronate—Eye disorder—Docetaxel—skin cancer	0.000229	0.000767	CcSEcCtD
Zoledronate—Abdominal pain—Dactinomycin—skin cancer	0.000228	0.000766	CcSEcCtD
Zoledronate—Body temperature increased—Dactinomycin—skin cancer	0.000228	0.000766	CcSEcCtD
Zoledronate—Hypersensitivity—Bleomycin—skin cancer	0.000228	0.000766	CcSEcCtD
Zoledronate—Decreased appetite—Temozolomide—skin cancer	0.000227	0.000762	CcSEcCtD
Zoledronate—Cardiac disorder—Docetaxel—skin cancer	0.000227	0.000762	CcSEcCtD
Zoledronate—Flushing—Docetaxel—skin cancer	0.000227	0.000762	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Temozolomide—skin cancer	0.000226	0.000757	CcSEcCtD
Zoledronate—Fatigue—Temozolomide—skin cancer	0.000225	0.000756	CcSEcCtD
Zoledronate—Hypotension—Fluorouracil—skin cancer	0.000225	0.000755	CcSEcCtD
Zoledronate—Pain—Temozolomide—skin cancer	0.000223	0.00075	CcSEcCtD
Zoledronate—Constipation—Temozolomide—skin cancer	0.000223	0.00075	CcSEcCtD
Zoledronate—Asthenia—Bleomycin—skin cancer	0.000222	0.000746	CcSEcCtD
Zoledronate—Angiopathy—Docetaxel—skin cancer	0.000222	0.000745	CcSEcCtD
Zoledronate—Immune system disorder—Docetaxel—skin cancer	0.000221	0.000741	CcSEcCtD
Zoledronate—Mediastinal disorder—Docetaxel—skin cancer	0.00022	0.00074	CcSEcCtD
Zoledronate—Chills—Docetaxel—skin cancer	0.000219	0.000736	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000219	0.000736	CcSEcCtD
Zoledronate—Pruritus—Bleomycin—skin cancer	0.000219	0.000735	CcSEcCtD
Zoledronate—Arrhythmia—Docetaxel—skin cancer	0.000218	0.000733	CcSEcCtD
Zoledronate—Insomnia—Fluorouracil—skin cancer	0.000218	0.000731	CcSEcCtD
Zoledronate—Paraesthesia—Fluorouracil—skin cancer	0.000216	0.000725	CcSEcCtD
Zoledronate—Alopecia—Docetaxel—skin cancer	0.000216	0.000725	CcSEcCtD
Zoledronate—Feeling abnormal—Temozolomide—skin cancer	0.000215	0.000722	CcSEcCtD
Zoledronate—Dyspnoea—Fluorouracil—skin cancer	0.000215	0.00072	CcSEcCtD
Zoledronate—Mental disorder—Docetaxel—skin cancer	0.000214	0.000719	CcSEcCtD
Zoledronate—Somnolence—Fluorouracil—skin cancer	0.000214	0.000718	CcSEcCtD
Zoledronate—Gastrointestinal pain—Temozolomide—skin cancer	0.000214	0.000717	CcSEcCtD
Zoledronate—Erythema—Docetaxel—skin cancer	0.000213	0.000714	CcSEcCtD
Zoledronate—Malnutrition—Docetaxel—skin cancer	0.000213	0.000714	CcSEcCtD
Zoledronate—Hypersensitivity—Dactinomycin—skin cancer	0.000213	0.000714	CcSEcCtD
Zoledronate—Dyspepsia—Fluorouracil—skin cancer	0.000212	0.000711	CcSEcCtD
Zoledronate—Decreased appetite—Fluorouracil—skin cancer	0.000209	0.000702	CcSEcCtD
Zoledronate—Dysgeusia—Docetaxel—skin cancer	0.000208	0.0007	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000208	0.000697	CcSEcCtD
Zoledronate—Urticaria—Temozolomide—skin cancer	0.000208	0.000696	CcSEcCtD
Zoledronate—Asthenia—Dactinomycin—skin cancer	0.000207	0.000695	CcSEcCtD
Zoledronate—Abdominal pain—Temozolomide—skin cancer	0.000207	0.000693	CcSEcCtD
Zoledronate—Body temperature increased—Temozolomide—skin cancer	0.000207	0.000693	CcSEcCtD
Zoledronate—Back pain—Docetaxel—skin cancer	0.000206	0.000691	CcSEcCtD
Zoledronate—Pain—Fluorouracil—skin cancer	0.000206	0.000691	CcSEcCtD
Zoledronate—Muscle spasms—Docetaxel—skin cancer	0.000205	0.000687	CcSEcCtD
Zoledronate—Feeling abnormal—Fluorouracil—skin cancer	0.000198	0.000666	CcSEcCtD
Zoledronate—Diarrhoea—Dactinomycin—skin cancer	0.000198	0.000663	CcSEcCtD
Zoledronate—Vomiting—Bleomycin—skin cancer	0.000197	0.000661	CcSEcCtD
Zoledronate—Anaemia—Docetaxel—skin cancer	0.000197	0.00066	CcSEcCtD
Zoledronate—Rash—Bleomycin—skin cancer	0.000195	0.000655	CcSEcCtD
Zoledronate—Dermatitis—Bleomycin—skin cancer	0.000195	0.000655	CcSEcCtD
Zoledronate—Hypersensitivity—Temozolomide—skin cancer	0.000193	0.000646	CcSEcCtD
Zoledronate—Urticaria—Fluorouracil—skin cancer	0.000191	0.000642	CcSEcCtD
Zoledronate—Syncope—Docetaxel—skin cancer	0.000191	0.000641	CcSEcCtD
Zoledronate—Leukopenia—Docetaxel—skin cancer	0.000191	0.000639	CcSEcCtD
Zoledronate—Body temperature increased—Fluorouracil—skin cancer	0.00019	0.000639	CcSEcCtD
Zoledronate—Palpitations—Docetaxel—skin cancer	0.000188	0.000631	CcSEcCtD
Zoledronate—Asthenia—Temozolomide—skin cancer	0.000187	0.000629	CcSEcCtD
Zoledronate—Loss of consciousness—Docetaxel—skin cancer	0.000187	0.000628	CcSEcCtD
Zoledronate—Cough—Docetaxel—skin cancer	0.000186	0.000623	CcSEcCtD
Zoledronate—Pruritus—Temozolomide—skin cancer	0.000185	0.00062	CcSEcCtD
Zoledronate—Convulsion—Docetaxel—skin cancer	0.000184	0.000619	CcSEcCtD
Zoledronate—Nausea—Bleomycin—skin cancer	0.000184	0.000617	CcSEcCtD
Zoledronate—Hypertension—Docetaxel—skin cancer	0.000184	0.000617	CcSEcCtD
Zoledronate—Vomiting—Dactinomycin—skin cancer	0.000184	0.000616	CcSEcCtD
Zoledronate—Rash—Dactinomycin—skin cancer	0.000182	0.000611	CcSEcCtD
Zoledronate—Arthralgia—Docetaxel—skin cancer	0.000181	0.000608	CcSEcCtD
Zoledronate—Chest pain—Docetaxel—skin cancer	0.000181	0.000608	CcSEcCtD
Zoledronate—Myalgia—Docetaxel—skin cancer	0.000181	0.000608	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00018	0.000604	CcSEcCtD
Zoledronate—Diarrhoea—Temozolomide—skin cancer	0.000179	0.0006	CcSEcCtD
Zoledronate—Hypersensitivity—Fluorouracil—skin cancer	0.000177	0.000595	CcSEcCtD
Zoledronate—Dry mouth—Docetaxel—skin cancer	0.000177	0.000595	CcSEcCtD
Zoledronate—Confusional state—Docetaxel—skin cancer	0.000175	0.000588	CcSEcCtD
Zoledronate—Oedema—Docetaxel—skin cancer	0.000174	0.000583	CcSEcCtD
Zoledronate—Anaphylactic shock—Docetaxel—skin cancer	0.000174	0.000583	CcSEcCtD
Zoledronate—Dizziness—Temozolomide—skin cancer	0.000173	0.00058	CcSEcCtD
Zoledronate—Infection—Docetaxel—skin cancer	0.000173	0.000579	CcSEcCtD
Zoledronate—Nausea—Dactinomycin—skin cancer	0.000172	0.000576	CcSEcCtD
Zoledronate—Shock—Docetaxel—skin cancer	0.000171	0.000574	CcSEcCtD
Zoledronate—Nervous system disorder—Docetaxel—skin cancer	0.00017	0.000572	CcSEcCtD
Zoledronate—Pruritus—Fluorouracil—skin cancer	0.00017	0.000571	CcSEcCtD
Zoledronate—Thrombocytopenia—Docetaxel—skin cancer	0.00017	0.000571	CcSEcCtD
Zoledronate—Tachycardia—Docetaxel—skin cancer	0.00017	0.000569	CcSEcCtD
Zoledronate—Skin disorder—Docetaxel—skin cancer	0.000169	0.000566	CcSEcCtD
Zoledronate—Vomiting—Temozolomide—skin cancer	0.000166	0.000557	CcSEcCtD
Zoledronate—Anorexia—Docetaxel—skin cancer	0.000166	0.000556	CcSEcCtD
Zoledronate—Rash—Temozolomide—skin cancer	0.000165	0.000553	CcSEcCtD
Zoledronate—Diarrhoea—Fluorouracil—skin cancer	0.000165	0.000553	CcSEcCtD
Zoledronate—Dermatitis—Temozolomide—skin cancer	0.000165	0.000552	CcSEcCtD
Zoledronate—Headache—Temozolomide—skin cancer	0.000164	0.000549	CcSEcCtD
Zoledronate—Hypotension—Docetaxel—skin cancer	0.000162	0.000545	CcSEcCtD
Zoledronate—Dizziness—Fluorouracil—skin cancer	0.000159	0.000534	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000158	0.000531	CcSEcCtD
Zoledronate—Insomnia—Docetaxel—skin cancer	0.000157	0.000527	CcSEcCtD
Zoledronate—Paraesthesia—Docetaxel—skin cancer	0.000156	0.000524	CcSEcCtD
Zoledronate—Nausea—Temozolomide—skin cancer	0.000155	0.000521	CcSEcCtD
Zoledronate—Dyspnoea—Docetaxel—skin cancer	0.000155	0.00052	CcSEcCtD
Zoledronate—Somnolence—Docetaxel—skin cancer	0.000154	0.000518	CcSEcCtD
Zoledronate—Vomiting—Fluorouracil—skin cancer	0.000153	0.000514	CcSEcCtD
Zoledronate—Dyspepsia—Docetaxel—skin cancer	0.000153	0.000513	CcSEcCtD
Zoledronate—Rash—Fluorouracil—skin cancer	0.000152	0.000509	CcSEcCtD
Zoledronate—Dermatitis—Fluorouracil—skin cancer	0.000152	0.000509	CcSEcCtD
Zoledronate—Decreased appetite—Docetaxel—skin cancer	0.000151	0.000507	CcSEcCtD
Zoledronate—Headache—Fluorouracil—skin cancer	0.000151	0.000506	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Docetaxel—skin cancer	0.00015	0.000503	CcSEcCtD
Zoledronate—Fatigue—Docetaxel—skin cancer	0.00015	0.000503	CcSEcCtD
Zoledronate—Pain—Docetaxel—skin cancer	0.000149	0.000499	CcSEcCtD
Zoledronate—Constipation—Docetaxel—skin cancer	0.000149	0.000499	CcSEcCtD
Zoledronate—Feeling abnormal—Docetaxel—skin cancer	0.000143	0.00048	CcSEcCtD
Zoledronate—Nausea—Fluorouracil—skin cancer	0.000143	0.00048	CcSEcCtD
Zoledronate—Gastrointestinal pain—Docetaxel—skin cancer	0.000142	0.000477	CcSEcCtD
Zoledronate—Body temperature increased—Docetaxel—skin cancer	0.000137	0.000461	CcSEcCtD
Zoledronate—Abdominal pain—Docetaxel—skin cancer	0.000137	0.000461	CcSEcCtD
Zoledronate—Hypersensitivity—Docetaxel—skin cancer	0.000128	0.00043	CcSEcCtD
Zoledronate—Asthenia—Docetaxel—skin cancer	0.000125	0.000418	CcSEcCtD
Zoledronate—Pruritus—Docetaxel—skin cancer	0.000123	0.000412	CcSEcCtD
Zoledronate—Diarrhoea—Docetaxel—skin cancer	0.000119	0.000399	CcSEcCtD
Zoledronate—Dizziness—Docetaxel—skin cancer	0.000115	0.000386	CcSEcCtD
Zoledronate—Vomiting—Docetaxel—skin cancer	0.00011	0.000371	CcSEcCtD
Zoledronate—Rash—Docetaxel—skin cancer	0.00011	0.000368	CcSEcCtD
Zoledronate—Dermatitis—Docetaxel—skin cancer	0.000109	0.000367	CcSEcCtD
Zoledronate—Headache—Docetaxel—skin cancer	0.000109	0.000365	CcSEcCtD
Zoledronate—Nausea—Docetaxel—skin cancer	0.000103	0.000346	CcSEcCtD
